Product Name :
PF-06409577
CAS No.:
1467057-23-3
Purity :
> 97%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
OC(=O)C1=C[NH]C2=CC(=C(C=C12)C3=CC=C(C=C3)C4(O)CCC4)Cl
Product Description :
PF-06409577 is orally bioavailable AMPK activator with EC50 of 7 nM for α1β1γ1 in the TR-FRET assay and it shows no detectable inhibition of hERG in a patch-clamp assay (100 μM) and was not an inhibitor (IC50 > 100 μM) of the microsomal activities of major human cytochrome P450 isoforms.
Formula:
C19H16ClNO3
Molecular Weight :
341.{{Efalizumab} medchemexpress|{Efalizumab} Integrin|{Efalizumab} Technical Information|{Efalizumab} Data Sheet|{Efalizumab} custom synthesis|{Efalizumab} Epigenetic Reader Domain} 79
Synonyms:
Additional Information:
|CAS No.{{Pyrazinamide} web|{Pyrazinamide} Anti-infection|{Pyrazinamide} Biological Activity|{Pyrazinamide} Formula|{Pyrazinamide} supplier|{Pyrazinamide} Cancer} 1467057-23-3 ; |Formula C19H16ClNO3 ; |Molecular Weight 341.PMID:23935843 79 ; |SMILES OC(=O)C1=C[NH]C2=CC(=C(C=C12)C3=CC=C(C=C3)C4(O)CCC4)Cl ; |Product Description PF-06409577 is orally bioavailable AMPK activator with EC50 of 7 nM for α1β1γ1 in the TR-FRET assay and it shows no detectable inhibition of hERG in a patch-clamp assay (100 μM) and was not an inhibitor (IC50 > 100 μM) of the microsomal activities of major human cytochrome P450 isoforms. ; |Purity > 97% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO